Rallis India Q1 net profit jumps 31% to ₹125 cr on higher revenues
AI Summary
Rallis India reported a robust 31% increase in net profits for Q1 FY2026, reaching ₹125 crore, driven by a 7% rise in revenues to ₹1,022 crore, primarily from strong domestic formulation growth. The company's Crop Care and Seeds segments showed positive performance, with new product launches and strategic initiatives contributing to profitability and market expansion.
Rallis India reported a 31 per cent rise in net profits for the first quarter of current financial year ending June, 2026, at ₹125 crore against corresponding last quarter’s ₹95 crore on higher revenues.
Revenues were up 7 per cent at ₹1,022 crore against corresponding last quarter’s ₹957 crore, led by double digit growth in domestic formulation. EBITDA increased by 23 per cent to ₹184 crore from corresponding last quarter’s ₹150 crore.
Gyanendra Shukla, Managing Director & CEO, Rallis India Limited, said, “During the quarter, we continued to strengthen our product portfolio through new product introductions across businesses while driving improved profitability through disciplined pricing actions and cost optimisation initiatives. We remain committed to delivering differentiated solutions that address the evolving needs of Indian agriculture through continued investments in innovation, customer-centricity and operational excellence.”
Rallis’ Crop Care business reported revenue of ₹697 crore, registering a growth of 7 per cent year-on-year (y-o-y), primarily driven by strong growth of 19 per cent in the B2C segment, partially offset by a decline of 19 per cent in the B2B segment during the quarter. The company launched three new products – Balwan (Herbicide), Prodim Ultra (Herbicide) and Kengen (Insecticide). Strategic product placements, targeted field programmes and focused liquidation initiatives further supported business performance during the quarter, the company said.
The Soil & Plant Health (SPH) segment delivered a growth of 10 per cent y-o-y, supported by focused portfolio management, prudent pricing actions and continued contribution from biostimulants, biofertilisers, and organic products. The commercial launch of Aquafert ginger and turmeric further strengthened the portfolio during the quarter.
The Seeds business reported revenue of ₹325 crore, registering a growth of 6 per cent y-o-y, driven by strategic product placements and focused pre-season initiatives. During the quarter, the business strengthened its portfolio with the launch of nine new products across cotton, paddy and millet crops, including two new cotton hybrids for North India and a Herbicide Tolerant Direct Seed Rice product under the Dhaanya brand.
Original Article
Published on Hindu BusinessLine